Andhra Pradesh’s fourth statewide screening for non-communicable diseases, NCD 4.0, reached 2.85 crore adults over 14 months. It found 12.23 lakh people with previously undiagnosed hypertension and 11.59 lakh with undiagnosed diabetes, and confirmed 12,768 cases of oral, breast and cervical cancer. The figures come from the state health department and have not been peer-reviewed. Even so, they show how much chronic disease goes undetected until someone looks, and how much work remains once it is found.
High blood pressure and type 2 diabetes rarely announce themselves. Many people live with them for years without symptoms while damage builds in the heart, kidneys, eyes and blood vessels. That is why population screening matters. Andhra Pradesh’s latest round, whose results were reported on Sunday evening, is one of the largest such exercises in the country.
What the survey found
According to figures from the state health department reported by Deccan Chronicle and The Hans India, NCD 4.0 ran for 14 months and ended on 10 November. Health workers screened about 2.85 crore adults for hypertension, diabetes and three common cancers.
The main findings:
- Hypertension: 12.23 lakh new cases detected. The state now counts 59.63 lakh adults with hypertension, including those previously known.
- Diabetes: 11.59 lakh new cases detected (South First reports 11.58 lakh).
- Cancer: 12,768 confirmed cases of oral, breast and cervical cancer after screening and follow-up investigation.
Taken together, roughly 24 lakh adults learned for the first time that they have at least one of the two most common chronic diseases. The Hans India headlined the story with “1.08 crore people” living with diabetes or high blood pressure. That figure appears to add the totals for each condition, counting twice the many people who have both. The number of individuals affected is therefore lower. NSH could not obtain the state’s de-duplicated count from an official document, and readers should treat the 1.08 crore figure as an upper bound.
How screening of this kind works
India’s national programme for non-communicable diseases recommends population-based screening of adults aged 30 and above. Frontline health workers record blood pressure with a digital monitor, check blood glucose with a finger-prick test, and carry out oral visual examination. Women are offered clinical breast examination and cervical screening, typically by visual inspection with acetic acid. Anyone who screens positive is referred to a primary health centre or hospital for confirmation. (This describes national guidance in general terms; the exact protocol used in NCD 4.0 was not published in the reports NSH reviewed.)
That last step is important. A single raised blood-pressure reading or glucose test is not a diagnosis. The reported “new cases” are therefore best understood as people flagged by screening and, in the state’s account, confirmed. The cancer figure explicitly refers to confirmed cases. For hypertension and diabetes, the reports do not say how many people were confirmed by repeat testing.
Putting the numbers in context
National surveys have long suggested that a large share of Indians with hypertension or diabetes do not know it. The ICMR-INDIAB study, published in The Lancet Diabetes & Endocrinology in 2023, estimated diabetes prevalence across India at about 11% of adults and hypertension at about 35%. It found wide variation between states, and southern states generally had higher rates. NSH has not re-verified these figures for this edition, and they are not directly comparable with the Andhra Pradesh screening, which used different methods and reached a different population.
What the state data do show is the size of the “care gap”. Each newly detected person now needs follow-up testing, lifestyle advice, and in many cases lifelong medication and regular monitoring. Detection without sustained treatment changes little. The real measure of a screening programme is how many people are subsequently brought under control: blood pressure below target, blood sugar managed, and complications prevented.
The cancer findings
The 12,768 confirmed cancers are in some ways the most consequential number. Oral, breast and cervical cancers are among the most common in India. All three can be treated far more successfully when they are found early. Oral cancer is closely linked to tobacco and areca nut use. Cervical cancer is largely preventable through HPV vaccination and screening, and India began rolling out HPV vaccination for adolescent girls in recent years. The reports do not give the stage at which these cancers were found, which is what determines how many lives the screening may save.
Limitations
The figures are the state government’s own and have not been independently audited or published in a peer-reviewed journal. The reports give no age or district breakdown and no information on how many people declined screening. They also do not say how many of those referred completed confirmatory tests, or how many have started treatment. Comparisons with earlier NCD rounds were not available. NSH will seek the official report.
Why it matters beyond Andhra Pradesh
Large-scale screening is expensive and logistically demanding, but chronic disease is now India’s leading health burden. Andhra Pradesh’s exercise offers a test of whether door-to-door detection can be connected to reliable follow-up. If the state publishes treatment and control rates in the coming months, its data could inform how other states design their programmes. For Telangana and other neighbouring states, which face similar dietary and demographic patterns, the Andhra Pradesh experience is directly relevant. The practical lessons, such as how many health workers were needed, how referrals were tracked and where people dropped out of care, may prove as valuable as the headline totals.
What to watch
- Publication of district-level and age-wise data.
- The state’s plan for follow-up: drug supply at primary health centres, tele-consultation and monitoring.
- Treatment outcomes for the 12,768 people diagnosed with cancer.
– Aditya Raja



